A 61-year-old woman with a medical history of ulcerative colitis (UC) developed an erythematous, mildly pruritic, maculopapular rash that was histologically consistent with reactive granulomatous dermatitis (RGD) with interstitial granulomatous dermatitis (IGD)-type features 1 week after vedolizumab infusion. Awareness of this complication is key to enhanced recognition and appropriate management as use of this medication becomes more prevalent.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.12788/cutis.0467 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!